VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 544.51B
Enterprise Value 340.79B
Trailing P/E 20.94
Forward P/E 128.63
PEG Ratio (5 yr expected) 10.85
Price/Sales (ttm)13.63
Price/Book (mrq)9.43
Enterprise Value/Revenue 312.49
Enterprise Value/EBITDA 645.56

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 66.01%
Operating Margin (ttm)24.87%

Management Effectiveness

Return on Assets (ttm)9.67%
Return on Equity (ttm)59.50%

Income Statement

Revenue (ttm)3.27B
Revenue Per Share (ttm)12.81
Quarterly Revenue Growth (yoy)34.00%
Gross Profit (ttm)1.22B
EBITDA 895.17M
Net Income Avi to Common (ttm)2.15B
Diluted EPS (ttm)8.30
Quarterly Earnings Growth (yoy)27.80%

Balance Sheet

Total Cash (mrq)3.48B
Total Cash Per Share (mrq)13.58
Total Debt (mrq)667.11M
Total Debt/Equity (mrq)14.12
Current Ratio (mrq)3.78
Book Value Per Share (mrq)18.42

Cash Flow Statement

Operating Cash Flow (ttm)1.34B
Levered Free Cash Flow (ttm)938.96M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.22
52-Week Change 312.22%
S&P500 52-Week Change 34.08%
52 Week High 3195.81
52 Week Low 3145.37
50-Day Moving Average 3170.07
200-Day Moving Average 3178.05

Share Statistics

Avg Vol (3 month) 31.25M
Avg Vol (10 day) 31.13M
Shares Outstanding 5256.12M
Float 255.88M
% Held by Insiders 10.26%
% Held by Institutions 196.96%
Shares Short (May 31, 2019) 43.67M
Short Ratio (May 31, 2019) 43.23
Short % of Float (May 31, 2019) 41.59%
Short % of Shares Outstanding (May 31, 2019) 41.43%
Shares Short (prior month Apr 30, 2019) 44.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Aug 24, 2000